DUBAI: Canadian Specialist Hospital (CSH) announced the opening of a state-of-the-art daycare cancer center in Dubai, in collaboration with India’s leading healthcare provider Max Healthcare. This highly specialized advanced center for cancer care will help patients improve their cancer therapy regimens.
Dr Maryam Al Rayssi, CEO of Dubai Hospital, inaugurated the oncology daycare centre in the presence of Mohammad Rashid Al Falasi, Chairman of Canadian Specialist Hospital and other senior officials and medical professionals.
The new care model will be at par with the best-in-class available clinical expertise and medical technologies along with personalized care in an ‘un-hospital’ like environment so that it can cater to the growing needs of patients in Dubai and its neighborhood. The amenities available at this center are intended to enhance patient experience while undergoing therapy for cancer.
The center will provide treatment to a variety of adult and pediatric cancers such as breast, lung, liver, colon, colorectal, stomach, prostate, brain, leukemia, cervix, kidney, pancreas, esophagus, ovarian sarcomas and other common and rare cancers, among the UAE nationals, residents and medical tourists. The center will soon expand to include surgical oncology services.
Commenting on the oncology center launch, Mohammad Rashid Al Falasi, said, “Canadian Specialist Hospital has been in the forefront of providing quality care to its patients in the UAE and beyond. We are glad to partner with India’s healthcare major Max Healthcare to open this unique cancer care wing at our hospital. This is aimed at addressing the need gaps in cancer care in the UAE and the region. We also understand there is urgent need of quality treatment for cancer here. We are committed to meeting the healthcare needs of the UAE local population and residents, offering them a range of advanced treatments through our center of excellence.”
Dr. Harit Chaturvedi, Chairman of MICC, said, “We are glad that we will be providing our expertise in Dubai to benefit patients through this unique collaboration. We have started with the medical oncology facility and will eventually extend support by providing surgical oncologists. We, at MICC, understand that a patient’s journey from the time of diagnosis and planning to implementation and follow up is a complex process.”
“Hence, we offer treatment that involves multiple specialties (Surgical, medical and radiation oncology, molecular oncology, pathology, radiology, palliative oncology, onco-psychology, onco-rehabilitation and so forth), and the best outcome in any patient can be ensured only if all decisions are taken collectively by all specialists involved,” he added.
According to Dr Chaturvedi, cancer is a growing disease worldwide. “To make matters worse, the global pandemic has emerged as a nightmare with most patients delaying diagnosis as well as treatment due to the fear attached to contracting the virus. In addition, stalling international travel is also proving costly for many patients who may not have access to advanced treatment modalities in their region.”
Operation of the center will be led by Dr Prasanta Das, noted oncologist from Max Health Institute (MHIL). An in-house video conferencing facility will help connecting MHIL specialists to conduct tumor boards from Dubai between the two hospitals. The patients at CSH will have full access to the knowledge, skills and processes of the MICC.
Dr Ankur Bahl, Senior Consultant at MICC will travel to CSH on a regular basis and will be available at the hospital for in-person consultations.
MICC is one of the largest cancer services in North India, serving over 100,000 out patients and 15,000 in patients annually. MICC has over 90 oncologists and 30 patient navigators. MICC is one of the first healthcare providers to segregate organ-based treatment modalities called Disease Management Groups (DMGs).
Canadian Specialist Hospital is the institution of choice for referrals from small and medium-sized medical centers for specialized diagnostic and treatments.
-Ends-
About Canadian Specialist Hospital
CSH is one of the most advanced and comprehensive healthcare institutions in the Arab region with a capacity of 200 plus beds. It began its journey as a day care hospital with merely 20 beds facilitated in about 10 departments in 2004. The hospital was founded by its Chairman Mr. Mohammad Rashid Al Falasi with a vision to establish a hospital that provides world-class medical facility and caters to the tertiary health care needs while offering state-of-the-art diagnostic, curative and rehabilitative services at international standards with evidence-based ethical healthcare for a healthy and happy community. The multi-specialty hospital features qualified doctors trained from prestigious institutes around the world and a state-of-the-art laboratory and imaging department. Over the years, the hospital has established itself as one of the most advanced and comprehensive healthcare institutions in the region. The hospital currently offers 36+ specialties including cardiology, dermatology, gastroenterology, pulmonology, nephrology, dialysis and a rehabilitation department. The rehabilitation department provides services for orthopedic, neurological, cardiac, oncological and metabolic treatment. To know more about Canadian Specialist Hospital, visit http://www.csh.ae
About Max Healthcare:
Max Healthcare Institute Limited (MHIL) is one of India’s leading provider of healthcare services. It is committed to the highest standards of medical and service excellence, patient care, scientific and medical education. MHIL has major concentration in North India consisting of a network of 16 healthcare facilities. Out of the total network, eight hospitals and four medical centres are located in Delhi and the NCR and the others are located in the cities of Mumbai, Mohali, Bathinda and Dehradun. The Max network includes all the hospitals and medical centres owned and operated by the Company and its subsidiaries, and partner healthcare facilities. These include state-of-the-art tertiary and quaternary care hospitals at Saket, Patparganj, Vaishali, Rajendra Place, and Shalimar Bagh in Delhi NCR and one each in Mumbai, Mohali, Bathinda and Dehradun, secondary care hospital in Gurgaon and Day Care Centres at Noida, Lajpat Nagar and Panchsheel Park in NCR Delhi (India). The hospitals in Mohali and Bathinda are under PPP arrangement with the Government of Punjab, India. In addition to its core hospital business, MHIL has two SBUs - Max@Home and MaxLab. Max@Home is a platform that provides health and wellness services at home and MaxLab offers diagnostic services to patients outside its network.
About Max Institute of Cancer Care:
From a humble beginning in 2009, Max Institute of Cancer Care (MICC) has come a long way over the decade in offering a holistic & comprehensive oncology program to patients from India and abroad. State of the art equipment, highly experienced and wholly committed team of over 90 Oncologist in Medical, Surgical , Radiation & Molecular Oncology and a specialised team of paramedics provides us the opportunity to offer cutting edge Comprehensive & Personalised program to Patients . Patients are at the centre of everything we do– from creating specialised Disease Management Group (DMG) team of oncologist who specialise in a limited number of tumour types, to strengthening them with DMG based tumour boards – where each new patient is discussed within this multi-disciplinary team, to a strong focus on education and research and close to 200 academic publication from Max in Oncology over the last 3 years, to Patient Navigators -who are empowered with the requisite information and communication skills to support patient care in complex multistep medical systems. We are able to provide treatment reach close to 15,000 New Patients Annually. MICC is part of the National Cancer Grid and the only Institute in India after TMH (Tata Memorial Hospital) to hold virtual tumour boards offering advice and expertise to multiple hospitals in India. At the Core of the Oncology program in MICC are the Disease Management Group (DMG) –10 in total, Reconstruction and Aesthetics, Molecular Oncology, Palliative Care & Psycho-Oncology program integrates with DMG’s to make the program comprehensive. MICC also offers preventive oncology (Tobacco Cessation Program, Low Dose CT etc.), wellness, survivorship clinics and Homecare based services to patients. MICC is also a pioneer in Precision and Molecular oncology offering targeted therapy and Immunotherapy to patients; multiple patients have benefitted from more favourable treatment outcomes, less side effects and shorter stay.
For media queries, please contact:
Rasheed Palliyalil
Watermelon Communications
Dubai, UAE
+97142833655
rasheed@watermelonme.com
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
